Skip to main content

Oyler John's Form 4 filing

BeOne Medicines Ltd. (ONC) · filed Mar 7, 2025

Accession no.
0001651308-25-000047
Filed
Mar 7, 2025
Trade date
Mar 5-6, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 11 non-derivative transactions and 1 derivative transaction. Open-market sales total $10.4M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Oyler JohnCIK 0001042047Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 5, 2025Ordinary SharesAGrant or awardAcquired+201,084$0.00$04,405,895Direct
Mar 6, 2025Ordinary SharesMOption exerciseAcquired+486,161$0.50+$243,080.54,892,056Direct
Mar 6, 2025American Depositary SharesMOption exerciseAcquired+40,109$6.50+$260,708.540,109Direct
Mar 6, 2025American Depositary SharesSSaleDisposed−3,500$256.91F9−$899,18536,609Direct
Mar 6, 2025American Depositary SharesSSaleDisposed−13,598$257.92F10−$3,507,196.1623,011Direct
Mar 6, 2025American Depositary SharesSSaleDisposed−8,200$258.91F11−$2,123,06214,811Direct
Mar 6, 2025American Depositary SharesSSaleDisposed−6,705$259.77F12−$1,741,757.858,106Direct
Mar 6, 2025American Depositary SharesSSaleDisposed−2,906$261.08F13−$758,698.485,200Direct
Mar 6, 2025American Depositary SharesSSaleDisposed−3,400$262.03F14−$890,9021,800Direct
Mar 6, 2025American Depositary SharesSSaleDisposed−1,700$262.97F15−$447,049100Direct
Mar 6, 2025American Depositary SharesSSaleDisposed−100$264.27−$26,4270Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 6, 2025Ordinary SharesMOption exerciseDisposed−1,007,578$0.00$06,559,391Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.28 to $257.19, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.41 to $258.39, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.44 to $259.38, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F12

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.44 to $260.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F13

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.50 to $261.45, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F14

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.56 to $262.38, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F15

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.81 to $263.37, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)